Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker

Title
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-11
DOI
10.3389/fphar.2022.950831

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started